Monitoring vaccine responses in immune compromised patients
Registry of Vaccine Responses in Immune Compromised Patients
This study is trying to see how well vaccines work and how safe they are for people with weakened immune systems.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 300 (estimated) |
| Sex | All |
| Sponsor | Pediatric Clinical Research Platform Academic / other |
| Locations | 1 site (Geneva) |
| Trial ID | NCT06463119 on ClinicalTrials.gov |
What this trial studies
This project aims to monitor and document vaccination responses, efficacy, and safety in immune compromised patients at various stages of their disease. It will collect data on vaccine responses and the evolution of serology against vaccine-preventable diseases over time. The study will also focus on optimizing vaccination status and standardizing practices for managing immunocompromised patients. By creating a registry, the project seeks to share expertise and improve vaccination strategies for this vulnerable population.
Who should consider this trial
Good fit: Ideal candidates include immune compromised patients or those who are about to become immunocompromised.
Not a fit: Patients who are not immune compromised or do not meet the inclusion criteria may not benefit from this study.
Why it matters
Potential benefit: If successful, this project could enhance vaccination strategies and improve health outcomes for immune compromised patients.
How similar studies have performed: Other studies have shown success in monitoring vaccine responses in similar populations, but this approach aims to standardize practices and create a comprehensive registry.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Immune compromised patient or patient who will soon be immunocompromised 2. Informed consent as documented by signature Exclusion Criteria: 1. Individual/parental inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, known/suspected non-compliance, substance abuse, etc. 2. Plan to move out of the country or have prolong absence in the next 2 months
Where this trial is running
Geneva
- University Hospitals of Geneva — Geneva, Switzerland (Recruiting)
Study contacts
- Principal investigator: Laure F Pittet, MD-PhD — University Hospitals of Geneva
- Study coordinator: Laure F Pittet, MD-PhD
- Email: laure.pittet@hcuge.ch
- Phone: 0223725481
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.